NeoPhore Ltd
Cambridge, United Kingdom (UK) · Health and Medical
Source
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
Sep 2025
Work here? Claim this profile
#Biotechnology
#Drug Discovery
#Small Molecule Therapeutics
#Oncology
#Immuno-oncology
#Cancer
#Genetics
#Translational Medicine
Overview
NeoPhore is creating novel small molecule immuno-oncology therapeutics. NeoPhore's drugs target genetic mechanisms that both clinical and lab validation studies suggest will promote neoantigen creation and diversity across numerous cancers. Alone or in combination with other cancer immunotherapies, drugs that spark cancer neoantigen creation are designed to stimulate the immune system and improve outcomes for patients who fail to benefit from the current generation of cancer immunity therapeutics.
Contact Details
info@neophore.com
Cambridge, United Kingdom (UK)
Founded
2017
Employees
10-20
Keywords
#Biotechnology
#Drug Discovery
#Small Molecule Therapeutics
#Oncology
#Immuno-oncology
#Cancer
#Genetics
#Translational Medicine
Companies teams usually look at after NeoPhore Ltd
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.